| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obstetric Labor, Premature | 17 | 2018 | 58 | 4.120 |
Why?
|
| Premature Birth | 13 | 2025 | 129 | 3.280 |
Why?
|
| Pregnancy Complications, Infectious | 9 | 2015 | 96 | 2.550 |
Why?
|
| Escherichia coli Infections | 9 | 2018 | 36 | 2.450 |
Why?
|
| Pregnancy | 45 | 2025 | 3147 | 2.350 |
Why?
|
| Labor, Obstetric | 3 | 2023 | 47 | 1.670 |
Why?
|
| Fetal Membranes, Premature Rupture | 3 | 2023 | 19 | 1.620 |
Why?
|
| Uterus | 13 | 2018 | 227 | 1.480 |
Why?
|
| Placenta | 11 | 2025 | 189 | 1.460 |
Why?
|
| Toll-Like Receptor 2 | 5 | 2020 | 36 | 1.440 |
Why?
|
| Diabetes, Gestational | 2 | 2022 | 49 | 1.370 |
Why?
|
| Inflammation | 9 | 2025 | 1050 | 1.180 |
Why?
|
| Myeloid Differentiation Factor 88 | 4 | 2015 | 58 | 1.170 |
Why?
|
| Cesarean Section | 3 | 2019 | 157 | 1.110 |
Why?
|
| Macrophages | 8 | 2022 | 610 | 0.990 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 2 | 2018 | 4 | 0.970 |
Why?
|
| Progesterone | 6 | 2023 | 112 | 0.900 |
Why?
|
| Escherichia coli | 6 | 2018 | 563 | 0.890 |
Why?
|
| Streptococcus agalactiae | 3 | 2015 | 13 | 0.860 |
Why?
|
| Glucose Tolerance Test | 2 | 2022 | 232 | 0.840 |
Why?
|
| Streptococcal Infections | 3 | 2015 | 56 | 0.840 |
Why?
|
| Pregnancy Complications | 3 | 2021 | 352 | 0.840 |
Why?
|
| Female | 52 | 2025 | 48702 | 0.840 |
Why?
|
| Physician-Patient Relations | 2 | 2018 | 576 | 0.780 |
Why?
|
| Isothiocyanates | 1 | 2022 | 7 | 0.770 |
Why?
|
| Phenol | 1 | 2022 | 7 | 0.760 |
Why?
|
| Toll-Like Receptor 4 | 5 | 2015 | 91 | 0.750 |
Why?
|
| Uterine Cervical Incompetence | 1 | 2022 | 4 | 0.750 |
Why?
|
| Cerclage, Cervical | 1 | 2022 | 5 | 0.750 |
Why?
|
| Mice | 26 | 2022 | 12269 | 0.710 |
Why?
|
| Perineum | 2 | 2014 | 37 | 0.690 |
Why?
|
| Interleukin-1 | 4 | 2006 | 71 | 0.660 |
Why?
|
| Myometrium | 2 | 2020 | 54 | 0.660 |
Why?
|
| Receptors, Progesterone | 3 | 2025 | 196 | 0.650 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2020 | 15 | 0.630 |
Why?
|
| Endometritis | 1 | 2019 | 2 | 0.630 |
Why?
|
| DNA Virus Infections | 1 | 2020 | 4 | 0.630 |
Why?
|
| Genital Diseases, Female | 1 | 2020 | 21 | 0.620 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2019 | 24 | 0.620 |
Why?
|
| Patient Care Bundles | 1 | 2019 | 20 | 0.610 |
Why?
|
| Poly I-C | 4 | 2015 | 19 | 0.580 |
Why?
|
| Receptors, Notch | 2 | 2015 | 138 | 0.540 |
Why?
|
| Infant, Newborn | 7 | 2025 | 2479 | 0.540 |
Why?
|
| Anger | 1 | 2018 | 80 | 0.540 |
Why?
|
| Animals | 31 | 2022 | 28155 | 0.530 |
Why?
|
| Patients | 1 | 2018 | 103 | 0.530 |
Why?
|
| Signal Transduction | 9 | 2015 | 3502 | 0.530 |
Why?
|
| Receptors, Interleukin-1 | 3 | 2006 | 10 | 0.520 |
Why?
|
| Peptidoglycan | 4 | 2015 | 30 | 0.520 |
Why?
|
| Surgical Wound Infection | 1 | 2019 | 237 | 0.520 |
Why?
|
| Cognition | 1 | 2021 | 627 | 0.500 |
Why?
|
| Toll-Like Receptors | 4 | 2011 | 102 | 0.490 |
Why?
|
| Unnecessary Procedures | 1 | 2016 | 42 | 0.480 |
Why?
|
| Vaginal Smears | 1 | 2016 | 71 | 0.480 |
Why?
|
| Lipopolysaccharides | 5 | 2018 | 301 | 0.470 |
Why?
|
| Patient Advocacy | 1 | 2016 | 63 | 0.460 |
Why?
|
| Medical Errors | 1 | 2016 | 94 | 0.460 |
Why?
|
| Humans | 32 | 2025 | 93515 | 0.430 |
Why?
|
| Obstetrics | 1 | 2016 | 123 | 0.430 |
Why?
|
| Platelet Activating Factor | 1 | 2014 | 53 | 0.430 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 2 | 2014 | 52 | 0.430 |
Why?
|
| Extraction, Obstetrical | 1 | 2014 | 7 | 0.420 |
Why?
|
| Obstetric Labor Complications | 1 | 2014 | 33 | 0.420 |
Why?
|
| Membrane Proteins | 4 | 2015 | 1264 | 0.410 |
Why?
|
| Inflammation Mediators | 5 | 2020 | 159 | 0.410 |
Why?
|
| RNA, Messenger | 4 | 2015 | 2026 | 0.410 |
Why?
|
| Neutrophils | 1 | 2015 | 324 | 0.410 |
Why?
|
| Mice, Knockout | 8 | 2015 | 2121 | 0.390 |
Why?
|
| Quality of Health Care | 1 | 2016 | 382 | 0.390 |
Why?
|
| Education, Medical | 1 | 2016 | 228 | 0.390 |
Why?
|
| Autophagy | 1 | 2015 | 172 | 0.390 |
Why?
|
| Obstetrical Forceps | 2 | 2014 | 9 | 0.390 |
Why?
|
| Vacuum Extraction, Obstetrical | 2 | 2014 | 7 | 0.390 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2016 | 318 | 0.380 |
Why?
|
| Fetus | 5 | 2015 | 236 | 0.380 |
Why?
|
| Bacterial Infections | 2 | 2005 | 179 | 0.380 |
Why?
|
| Lacerations | 2 | 2014 | 29 | 0.370 |
Why?
|
| Gestational Age | 5 | 2025 | 333 | 0.370 |
Why?
|
| Mice, Inbred C57BL | 9 | 2017 | 3435 | 0.360 |
Why?
|
| Chorioamnionitis | 3 | 2025 | 23 | 0.360 |
Why?
|
| Disease Models, Animal | 9 | 2017 | 2495 | 0.340 |
Why?
|
| Toll-Like Receptor 3 | 2 | 2010 | 12 | 0.340 |
Why?
|
| Decidua | 2 | 2025 | 22 | 0.340 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2016 | 624 | 0.330 |
Why?
|
| Cyclooxygenase 2 | 4 | 2015 | 99 | 0.330 |
Why?
|
| Meteorological Concepts | 1 | 2010 | 2 | 0.320 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 353 | 0.320 |
Why?
|
| Parturition | 1 | 2010 | 22 | 0.320 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2009 | 25 | 0.310 |
Why?
|
| Caspase Inhibitors | 1 | 2009 | 32 | 0.310 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2009 | 52 | 0.310 |
Why?
|
| Mice, Inbred C3H | 5 | 2017 | 369 | 0.300 |
Why?
|
| Gene Expression | 4 | 2015 | 1301 | 0.300 |
Why?
|
| Physicians | 1 | 2016 | 682 | 0.300 |
Why?
|
| Reperfusion Injury | 3 | 2017 | 148 | 0.290 |
Why?
|
| Seasons | 1 | 2010 | 240 | 0.290 |
Why?
|
| Interleukin-6 | 2 | 2015 | 276 | 0.290 |
Why?
|
| Hydroxyprostaglandin Dehydrogenases | 2 | 2005 | 6 | 0.280 |
Why?
|
| Labor Presentation | 1 | 2008 | 4 | 0.280 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2015 | 688 | 0.280 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 2005 | 36 | 0.280 |
Why?
|
| Cytokines | 5 | 2015 | 863 | 0.270 |
Why?
|
| Logistic Models | 2 | 2021 | 1243 | 0.250 |
Why?
|
| Vagina | 3 | 2012 | 177 | 0.250 |
Why?
|
| Internship and Residency | 1 | 2016 | 1090 | 0.250 |
Why?
|
| Case-Control Studies | 4 | 2020 | 1931 | 0.250 |
Why?
|
| Fetal Growth Retardation | 3 | 2017 | 72 | 0.240 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2006 | 40 | 0.240 |
Why?
|
| Pregnancy Trimester, Second | 2 | 2022 | 71 | 0.240 |
Why?
|
| Fetal Death | 3 | 2015 | 55 | 0.230 |
Why?
|
| Wound Healing | 3 | 2012 | 373 | 0.230 |
Why?
|
| NF-kappa B | 3 | 2015 | 408 | 0.230 |
Why?
|
| Receptors, Cell Surface | 2 | 2005 | 292 | 0.230 |
Why?
|
| Mice, Mutant Strains | 5 | 2013 | 224 | 0.230 |
Why?
|
| Retrospective Studies | 6 | 2025 | 10164 | 0.230 |
Why?
|
| Up-Regulation | 3 | 2018 | 730 | 0.220 |
Why?
|
| Interleukin-1beta | 2 | 2015 | 88 | 0.220 |
Why?
|
| Adult | 9 | 2025 | 27918 | 0.220 |
Why?
|
| Multivariate Analysis | 2 | 2019 | 985 | 0.220 |
Why?
|
| Membrane Glycoproteins | 2 | 2005 | 444 | 0.220 |
Why?
|
| Hydroxyprogesterones | 1 | 2023 | 15 | 0.200 |
Why?
|
| Enzymes | 1 | 2003 | 47 | 0.200 |
Why?
|
| Amniotic Fluid | 1 | 2023 | 30 | 0.190 |
Why?
|
| Cells, Cultured | 4 | 2015 | 2850 | 0.190 |
Why?
|
| Phenols | 1 | 2022 | 41 | 0.190 |
Why?
|
| Cell Line | 2 | 2020 | 2464 | 0.190 |
Why?
|
| Risk Factors | 3 | 2021 | 5899 | 0.180 |
Why?
|
| Cervix Uteri | 1 | 2022 | 73 | 0.180 |
Why?
|
| Polymerase Chain Reaction | 2 | 2020 | 894 | 0.180 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2012 | 86 | 0.180 |
Why?
|
| Pregnancy, Animal | 1 | 2002 | 58 | 0.180 |
Why?
|
| Clinical Competence | 2 | 2018 | 822 | 0.180 |
Why?
|
| Pregnancy Trimester, First | 1 | 2021 | 63 | 0.170 |
Why?
|
| Bias | 1 | 2021 | 137 | 0.170 |
Why?
|
| Torque teno virus | 1 | 2020 | 1 | 0.160 |
Why?
|
| Chlorhexidine | 1 | 2019 | 4 | 0.160 |
Why?
|
| Povidone-Iodine | 1 | 2019 | 9 | 0.160 |
Why?
|
| Mass Screening | 2 | 2022 | 696 | 0.150 |
Why?
|
| Glucose | 1 | 2022 | 692 | 0.150 |
Why?
|
| Uncertainty | 1 | 2020 | 78 | 0.150 |
Why?
|
| Uterine Diseases | 2 | 2013 | 19 | 0.150 |
Why?
|
| Skin | 2 | 2012 | 578 | 0.150 |
Why?
|
| Diagnostic Errors | 1 | 2020 | 157 | 0.140 |
Why?
|
| Blood Glucose | 1 | 2022 | 867 | 0.140 |
Why?
|
| Gene Expression Regulation | 3 | 2015 | 1985 | 0.140 |
Why?
|
| Administration, Intravenous | 1 | 2018 | 63 | 0.140 |
Why?
|
| Mice, Inbred Strains | 2 | 2015 | 280 | 0.140 |
Why?
|
| Body Mass Index | 1 | 2021 | 811 | 0.130 |
Why?
|
| Interleukins | 1 | 2018 | 133 | 0.130 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2015 | 296 | 0.130 |
Why?
|
| Fraud | 1 | 2016 | 6 | 0.130 |
Why?
|
| Patient Education as Topic | 1 | 2019 | 373 | 0.120 |
Why?
|
| Papanicolaou Test | 1 | 2016 | 39 | 0.120 |
Why?
|
| Quality Assurance, Health Care | 1 | 2018 | 225 | 0.120 |
Why?
|
| Malpractice | 1 | 2016 | 47 | 0.120 |
Why?
|
| Odds Ratio | 2 | 2015 | 711 | 0.120 |
Why?
|
| Immunohistochemistry | 3 | 2009 | 1799 | 0.120 |
Why?
|
| Polynucleotides | 1 | 2015 | 9 | 0.120 |
Why?
|
| Transcription Factor HES-1 | 1 | 2015 | 7 | 0.120 |
Why?
|
| Carrier State | 1 | 2015 | 40 | 0.120 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 1546 | 0.120 |
Why?
|
| Prospective Studies | 2 | 2020 | 4560 | 0.120 |
Why?
|
| Chemokines | 1 | 2015 | 76 | 0.110 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2015 | 5 | 0.110 |
Why?
|
| Autophagy-Related Protein 7 | 1 | 2015 | 12 | 0.110 |
Why?
|
| Autophagy-Related Proteins | 1 | 2015 | 23 | 0.110 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2015 | 21 | 0.110 |
Why?
|
| Calcium-Binding Proteins | 1 | 2015 | 119 | 0.110 |
Why?
|
| Phagosomes | 1 | 2015 | 40 | 0.110 |
Why?
|
| Recurrence | 2 | 2015 | 1190 | 0.110 |
Why?
|
| Caspases | 2 | 2018 | 151 | 0.110 |
Why?
|
| Cysteine Endopeptidases | 1 | 2015 | 88 | 0.110 |
Why?
|
| Maternal Age | 1 | 2014 | 48 | 0.110 |
Why?
|
| Cyclooxygenase 1 | 2 | 2005 | 5 | 0.110 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 192 | 0.110 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2014 | 35 | 0.110 |
Why?
|
| Male | 6 | 2018 | 44557 | 0.110 |
Why?
|
| Heterozygote | 1 | 2015 | 382 | 0.110 |
Why?
|
| Parity | 1 | 2014 | 97 | 0.110 |
Why?
|
| Lysosomes | 1 | 2015 | 123 | 0.100 |
Why?
|
| Models, Animal | 1 | 2015 | 282 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 836 | 0.100 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 179 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 436 | 0.100 |
Why?
|
| Clinical Decision-Making | 1 | 2016 | 291 | 0.100 |
Why?
|
| Epistasis, Genetic | 1 | 2014 | 90 | 0.100 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2015 | 185 | 0.100 |
Why?
|
| Proton-Translocating ATPases | 1 | 2013 | 24 | 0.100 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 200 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2005 | 216 | 0.100 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2013 | 109 | 0.100 |
Why?
|
| RNA | 2 | 2009 | 573 | 0.100 |
Why?
|
| Ligands | 2 | 2013 | 476 | 0.090 |
Why?
|
| Colpotomy | 1 | 2012 | 4 | 0.090 |
Why?
|
| Complement C5 | 1 | 2012 | 14 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2012 | 29 | 0.090 |
Why?
|
| Menopause | 1 | 2012 | 87 | 0.090 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 556 | 0.090 |
Why?
|
| Cell Membrane | 1 | 2014 | 664 | 0.090 |
Why?
|
| Surgeons | 1 | 2016 | 292 | 0.090 |
Why?
|
| Immunity, Innate | 2 | 2013 | 463 | 0.090 |
Why?
|
| Fatty Acids | 1 | 2011 | 145 | 0.080 |
Why?
|
| Peroxidase | 3 | 2017 | 54 | 0.080 |
Why?
|
| Gene-Environment Interaction | 1 | 2011 | 120 | 0.080 |
Why?
|
| Cell Line, Transformed | 1 | 2010 | 152 | 0.080 |
Why?
|
| Extraembryonic Membranes | 1 | 2009 | 8 | 0.080 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2009 | 122 | 0.080 |
Why?
|
| Ovarian Follicle | 1 | 2009 | 66 | 0.080 |
Why?
|
| Calpain | 1 | 2009 | 113 | 0.070 |
Why?
|
| Receptors, Interleukin | 1 | 2009 | 38 | 0.070 |
Why?
|
| Illinois | 1 | 2010 | 520 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 302 | 0.070 |
Why?
|
| Ovariectomy | 2 | 2012 | 91 | 0.070 |
Why?
|
| Apoptosis | 2 | 2013 | 1721 | 0.070 |
Why?
|
| Teichoic Acids | 1 | 2007 | 18 | 0.060 |
Why?
|
| Rabbits | 3 | 2012 | 618 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 887 | 0.060 |
Why?
|
| Receptors, Interleukin-1 Type I | 1 | 2006 | 5 | 0.060 |
Why?
|
| Cervical Ripening | 1 | 2006 | 5 | 0.060 |
Why?
|
| Infant | 2 | 2023 | 3220 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 1245 | 0.060 |
Why?
|
| Fetal Weight | 2 | 2017 | 16 | 0.060 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2005 | 69 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 7061 | 0.060 |
Why?
|
| Organ Size | 2 | 2017 | 362 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2005 | 1587 | 0.050 |
Why?
|
| DNA Primers | 1 | 2005 | 531 | 0.050 |
Why?
|
| 17-alpha-Hydroxyprogesterone | 1 | 2023 | 24 | 0.050 |
Why?
|
| Gravidity | 1 | 2023 | 7 | 0.050 |
Why?
|
| Prostaglandins | 1 | 2003 | 44 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 2484 | 0.050 |
Why?
|
| Proteomics | 1 | 2005 | 264 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2003 | 272 | 0.050 |
Why?
|
| Rats | 1 | 2009 | 4072 | 0.050 |
Why?
|
| Foam Cells | 1 | 2002 | 17 | 0.050 |
Why?
|
| Sialoglycoproteins | 1 | 2002 | 31 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 1917 | 0.050 |
Why?
|
| Genotype | 2 | 2003 | 1866 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 988 | 0.040 |
Why?
|
| Pregnancy Outcome | 1 | 2022 | 268 | 0.040 |
Why?
|
| Cholesterol | 1 | 2002 | 364 | 0.040 |
Why?
|
| Genomics | 1 | 2005 | 848 | 0.040 |
Why?
|
| Fas Ligand Protein | 1 | 2018 | 47 | 0.030 |
Why?
|
| Uterine Cervicitis | 1 | 2017 | 4 | 0.030 |
Why?
|
| Biomarkers | 2 | 2013 | 1910 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2023 | 2441 | 0.030 |
Why?
|
| Caspase 1 | 1 | 2013 | 20 | 0.030 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2013 | 26 | 0.030 |
Why?
|
| Hyaluronic Acid | 1 | 2013 | 53 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2013 | 98 | 0.020 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2011 | 7 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 307 | 0.020 |
Why?
|
| Boston | 1 | 2011 | 36 | 0.020 |
Why?
|
| Calcinosis | 1 | 2013 | 222 | 0.020 |
Why?
|
| Estrogens | 1 | 2012 | 195 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2011 | 115 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2012 | 674 | 0.020 |
Why?
|
| Mutation | 1 | 2002 | 4272 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2013 | 663 | 0.020 |
Why?
|
| Urban Population | 1 | 2011 | 234 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 300 | 0.020 |
Why?
|
| Young Adult | 2 | 2011 | 6930 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2011 | 826 | 0.020 |
Why?
|
| Cholates | 1 | 2002 | 1 | 0.010 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2002 | 15 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2002 | 165 | 0.010 |
Why?
|
| Lipoproteins | 1 | 2002 | 137 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2002 | 436 | 0.010 |
Why?
|
| Adolescent | 1 | 2011 | 9606 | 0.010 |
Why?
|